ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.
A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.
A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.
A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.
A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.
A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.
Read More
A hantavirus outbreak linked to the MV Hondius cruise ship killed three, including a Dutch couple, prompting global health containment efforts.
Read More
Researchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.
Read More
Eighteen Americans quarantined for 42 days in Omaha and Atlanta after Andes hantavirus outbreak on Dutch cruise ship MV Hondius caused three deaths.
Read More
Luis Rodríguez retired as chief of the CDC’s Vessel Sanitation Program amid a hantavirus outbreak and recent staff cuts, the agency announced.
Read More
A study of 440 women links accelerated monocyte aging to non-somatic depression symptoms, suggesting a potential early biomarker for mood-related depression.
Read More
A 2024 AMA report shows nearly one in three U.S. physicians face malpractice lawsuits, raising medical liability insurance premiums nationwide.
Read More
The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.
Read More
Representatives Miller-Meeks and Conaway introduced H.R. 8622 to reform Medicare’s MIPS by freezing thresholds, reducing penalties, and enhancing physician feedback.
Read More
Scientists isolated potent measles-blocking antibodies from a vaccinated patient, showing preventive and treatment effects in rodent models amid U.S. resurgence.
Read More
